Since 1990s, with the discovery of TRP channels, our understanding about nociception has changed
Lishizhen Med
this is an open access article distributed under the creative commons attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
One possibility would be combining GHK with antioxidants, such as the mitochondrial targeted antioxidant SS31 [23], given the role of redox imbalance in persistent lung fibrosis [15]
However, as with all peptides: Its not FDA-approved Its intended for research purposes in many jurisdictions Clinical trials are still limited Consult a qualified medical professional before starting any peptide therapy
In our experiments with DMF, we showed that the NRF2-GSH axis could be potentially targeted independently of melatonin